Anthony S. Gibney - Apr 15, 2024 Form 3 Insider Report for Clearside Biomedical, Inc. (CLSD)

Role
Director
Signature
/s/ Mark Ballantyne, Attorney-in-Fact
Stock symbol
CLSD
Transactions as of
Apr 15, 2024
Transactions value $
$0
Form type
3
Date filed
4/16/2024, 04:30 PM
Previous filing
Jul 13, 2023
Next filing
Apr 19, 2024

No securities are beneficially owned.